STEVENS CAPITAL MANAGEMENT LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$1,336,000
+106.5%
9,843
+215.0%
0.07%
+200.0%
Q2 2018$647,000
-12.0%
3,125
-56.8%
0.02%
-23.3%
Q4 2016$735,000
+51.2%
7,234
-20.8%
0.03%
+87.5%
Q4 2014$486,000
+50.0%
9,130
+32.5%
0.02%
+60.0%
Q3 2014$324,000
-71.0%
6,892
-61.6%
0.01%
-66.7%
Q2 2014$1,118,000
+117.9%
17,953
+135.6%
0.03%
+114.3%
Q1 2014$513,0007,6200.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders